reviewTop 1% cited
Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment
Biomedicine & Pharmacotherapy · 2018 · Vol. 101 · pp. 670–681
Lin Chen(Northwest University)Tian Yang(Ministry of Education of the People's Republic of China)Dewen Lu(Northwest University)Hui Zhao(Ministry of Education of the People's Republic of China)Ya‐Long Feng(Ministry of Education of the People's Republic of China)Hua Chen(Northwest University)Dan‐Qian Chen(Ministry of Education of the People's Republic of China)Nosratola D. Vaziri(University of California, Irvine)Ying‐Yong Zhao✉(Northwest University)
TGF-β signaling in diseasesRenal and related cancersChronic Kidney Disease and DiabetesSMADFibrosisInflammationMedicineKidney diseaseTransforming growth factorAngiotensin IIPathogenesisGlomerulosclerosisCancer research
MeSH terms
AnimalsHumansRenal AgentsSignal TransductionTransforming Growth Factor betaDrug Delivery SystemsTreatment OutcomeDisease ProgressionRenal Insufficiency, ChronicSmad Proteins
Funding
- National Natural Science Foundation of China
Citations
354
FWCI
14.38
field-weighted impact
References
199
Percentile
99%
vs. same field & year
Citations per year
References
Role of Smads in TGFβ signaling
Cell and Tissue Research · 2011 · 322 citations
Characterization of SIS3, a Novel Specific Inhibitor of Smad3, and Its Effect on Transforming Growth Factor-β1-Induced Extracellular Matrix Expression
Molecular Pharmacology · 2005 · 444 citations
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Nature Medicine · 2012 · 3,390 citations
TGF-β/Smad signaling in renal fibrosis
Frontiers in Physiology · 2015 · 640 citations
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Cell · 2003 · 5,831 citations
Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis
Frontiers in Pharmacology · 2017 · 554 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.